XB4-32047-02615 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-02
Registered in v-safe
2021-01-02
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-09
Dose 2 — Pfizer-BioNTech
2021-01-09
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · None

Adult check-in
2021-01-16
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-06
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-13
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-20
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-10
Survey response — 3 months, dose 2
MedDRA: Ageusia, Anosmia, COVID-19, Fatigue, Respiratory symptom — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Since last online check in, developed upper respiratory symptoms, loss of taste and smell and fatigue on 3/19. +COVID on 3/22. URI symptoms resolved. Fatigue gradually improving. Taste/smell changes persist.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-10
Survey response — 6 months, dose 2
MedDRA: Hospitalisation, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Pre-eclampsia with severe features · Healthcare visit (other): Admission for induction of labor

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-10
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-13
Call 1 — Could Not Reach Participant
2021-07-16
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-09	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-07-10	Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-10

Symptoms: Since last online check in, developed upper respiratory symptoms, loss of taste and smell and fatigue on 3/19. +COVID on 3/22. URI symptoms resolved. Fatigue gradually improving. Taste/smell changes persist.

Release 9 — 6 months, dose 2

2021-07-10

Symptoms: Pre-eclampsia with severe features

Healthcare visit (other): Admission for induction of labor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Hospitalisation	✓	✓	✓
SD	Ageusia	✓	✓	✓
SD	Anosmia	✓	✓	✓
SD	COVID-19	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Pre-eclampsia	✓	✓	✓
SD	Respiratory symptom	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release